Weight Watchers (WW) Q3 2026 earnings review
Weight Watchers lifts profit on ad cuts, but subscribers shrink
Weight Watchers lifted its third-quarter profit by cutting ad spending, but its subscriber base shrank across both medical and digital tiers. Revenue fell 11% from a year ago to $153 million as total subscribers dropped 23% to 2.3 million, while Adjusted EBITDA rose 21% to $52 million. New chief executive Stephen Bye joined in October and raised the bottom of the full-year profit outlook.
| Revenue | $152.9M -11.2% from a year ago |
|---|---|
| Total subscribers at period end | 2.30M -23.1% from a year ago |
| Adjusted EBITDA | $51.7M +21% from a year ago (33.8% margin) |
| Full-year outlook | Narrowed Revenue $627.5M mid; Clinical share cut to ~25% |
⚖️ Verdict: 🔴 Bearish
The story got worse because the medical weight-loss business shrank as soon as the company pulled back on marketing. Clinical subscribers fell by 23 thousand from the second quarter, forcing management to cut its full-year clinical revenue share target to the bottom of its prior range while basic digital losses continued. On the positive side, the ad pause generated $25 million in free cash flow and permanent leadership is now in place.
The question now is whether Weight Watchers can grow its medical and higher-priced digital tiers without spending heavily on ads every winter. Either higher prices per member and upgrades stabilize revenue, or subscriber losses resume whenever marketing slows. First-quarter subscriber additions and marketing spend will settle it.
🐂 Bull Case
Ad Cuts Lifted Q3 Profit Before Q4 Spend
Weight Watchers is managing costs while its revenue shrinks. Finance chief Felicia DellaFortuna said the weight-loss company is "proactively calibrating" its spending across its programs. In the third quarter, profit before interest, taxes, depreciation and one-offs (Adjusted EBITDA) rose 21% from a year ago to $51.7 million, or 33.8% of revenue, up 8.9 percentage points.
- Marketing expense: 21.6% of revenue, down 6.5 percentage points from a year ago
- Selling, general and administrative expense: 22.1% of revenue, down 12.8 percentage points from a year ago (or down 1.4 points excluding one-offs)
- Net income: $15.1 million, compared with a $4.4 million loss a year ago by our math before a one-time $53.2 million tax charge
The company called the period its "Lowest marketing quarter of the year, as planned, following elevated peak-season investment in Q1, particularly in Clinical". Because management kept only $2.5 million of the third-quarter profit beat in the full-year outlook, by our math fourth-quarter Adjusted EBITDA drops to $22.9 million, or 15.9% of revenue, as winter advertising begins. Earlier distribution partnerships received no new metrics in the release.
What to watch: first-quarter marketing spend as a share of revenue. A smaller seasonal ad bill that still adds subscribers would show the cost savings can last through a recruitment push.
Cash Rose by $25 Million, Narrowing Net Debt
Lower third-quarter marketing turned directly into cash on the balance sheet. After paying $36.8 million in the second quarter to retire $41.4 million of term-loan principal at a discount, the weight-management group rebuilt its cash cushion during the summer.
Operating cash flow reached $32.3 million in the third quarter, which included $11.4 million of quarterly interest payments on its term loan. Subtracting $7.0 million of capitalized software spending left $25.3 million of free cash flow by our math, lifting cash and cash equivalents from $101.5 million to $126.4 million. That reduced debt net of cash to $297.5 million by our math, against $424.0 million of gross long-term debt.
What to watch: unrestricted cash in the final ten days of the first quarter of 2027. Under the credit agreement, Weight Watchers must use any cash above $100 million during that window to pay down its term loan.
🐻 Bear Case
Clinical Subscribers Shrank After Marketing Pulled Back
DellaFortuna highlighted "the largest year-over-year Clinical Subscription Revenue growth percentage in any quarter of 2026 to date" as medical weight-loss revenue rose 48% from a year ago to $38.0 million. That lifted the clinical division to 25% of total revenue, up from 15% a year earlier, and pushed total monthly revenue per average subscriber up 14.3% to $21.17. Chief executive Stephen Bye said combining medical care with coaching "distinguishes our offering from others’ services limited to a prescription alone".
The year-ago comparison is flattering because the third quarter of 2025 was the low point after the company stopped selling compounded weight-loss drugs. From the second quarter of 2026, clinical subscribers fell by 23 thousand to 174 thousand, and clinical revenue dropped 4.7% by our math from $39.9 million. Monthly revenue per clinical subscriber held steady from the prior quarter at $68.25, so the drop came from losing members when advertising paused. As a result, Weight Watchers cut its full-year clinical revenue share outlook from 25–30% to about 25%.
What to watch: fourth-quarter clinical subscribers and monthly revenue per clinical member. By our math, hitting the 25% full-year mix target requires $40.1 million of fourth-quarter clinical revenue, up $2.1 million from the third quarter.
Basic Digital Losses Outrun Core+ Gains
Weight Watchers wants members in its Behavioral division — its non-medical weight-loss business — to choose Core+, a higher-priced tier that adds workshops, coaching and support for people taking GLP-1 weight-loss drugs prescribed elsewhere. Bye noted that Core+ grew subscribers for a fourth straight quarter, reaching 546 thousand, up 16% from a year ago, and that roughly one in five members upgrading from basic Core was taking a GLP-1 medication.
- Total Behavioral subscribers: 2.12 million, down 25.9% from a year ago and down 169 thousand in the quarter
- Core+ sequential gain: up 5 thousand from 541 thousand in the second quarter by our math
- Basic Core subscribers (Behavioral outside Core+): 1.58 million, down 34.1% from a year ago by our math
- Behavioral subscription revenue: $113.9 million, down 21.5% from a year ago
Adding 5 thousand Core+ members in three months could not offset losing 174 thousand basic Core members over the same period by our math. Even with behavioral monthly revenue per subscriber rising 5.0% from a year ago to $17.21, the shrinking base pulled total company revenue down 11.2%.
What to watch: first-quarter total Behavioral net subscriber additions during the winter diet season. A second consecutive winter decline would show that Core+ upgrades cannot stop total revenue from shrinking.
Risks this quarter didn't answer
Three standing balance-sheet and industry concerns received no updated figures in the third-quarter earnings release or shareholder letter.
- Goodwill and brand value: the Behavioral unit and $320 million trade name had less than 10% headroom at the May test, and the upcoming quarterly filing will show if a 25.9% Behavioral subscriber drop triggered a write-down.
- Debt terms and liquidity: the $424 million variable-rate term loan carries no revolving credit line and sweeps cash above $100 million each spring, making first-quarter cash burn the key test.
- Drug pricing and coverage: the release gave no update on how cheaper cash-pay GLP-1 drugs or the late-2027 end of Medicare bridge coverage will affect clinical sign-ups.
👓 Other Themes
Stephen Bye Joins as Chief Executive Officer
Stephen Bye became President and Chief Executive Officer on October 1, 2026, ending two quarters of interim leadership under DellaFortuna and operating chief Jon Volkmann after Tara Comonte left in March. Bye said, "My focus is on strengthening our member experience, improving our products and applications, and building on the work already underway". Weight Watchers recorded $1.4 million of executive transition costs in the quarter, bringing the nine-month total to $6.8 million.
💲 Other KPIs
Fell 20.6% from a year ago and 13.0% from the second quarter's $25.2 million by our math. Deferred revenue is cash members have paid upfront for subscription periods not yet delivered, so its drop tracks the 23.1% decline in total end-of-period subscribers and points to lower fourth-quarter revenue.
Rose 1.0 percentage point from the second quarter to its highest level of 2026, though down 0.5 points from 75.1% a year ago. Including depreciation and amortization, gross margin was 71.1%, down 1.0 point from last year. The company said fixed-cost cuts helped align staffing with lower subscriber volumes.
Dropped 30.7% from a year ago and 18.7% from the second quarter's $6.4 million run-rate. Management attributed the drop to operational efficiencies and "a higher proportion of development costs capitalized in connection with ongoing platform and digital experience enhancements", which lifted quarterly capitalized software spending to $7.0 million.
🔮 Guidance
Unchanged at the middle of the range. Weight Watchers narrowed the band by $5 million on each side, keeping the midpoint at $627.5 million, or an 11.7% drop from 2025 combined revenue by our math. That leaves $144.0 million for the fourth quarter by our math, down 11.6% from a year ago and down 5.8% from the third quarter.
Raised at the bottom of the range. Lifting the floor by $5 million moves the midpoint up $2.5 million to $112.5 million after holding at $110 million for three quarters. By our math, that leaves $22.9 million for the fourth quarter (a 15.9% margin, down from 33.8% in the third quarter), as the company spends on marketing "before we approach 2027 peak season".
Cut to the bottom of the prior range. "We now expect Clinical Subscription Revenue to be approximately 25% of 2026 total Revenue, up from 16% of 2025 total Revenue", the company wrote. By our math, 25% of the $627.5 million revenue midpoint equals $156.9 million for the year, leaving $40.1 million for the fourth quarter, up from $38.0 million in the third.
Raised. After delivering 73.9% across the first nine months and 74.6% in the third quarter, the weight-management group lifted its full-year target to approximately 74.0%, which still marks a slight drop from 2025. By our math, that leaves the fourth-quarter margin at 74.3%.
Improved on interest, unchanged on taxes. Full-year interest cost now sits at the bottom of the prior $45–50 million band following the second-quarter debt paydown. With $33.9 million of interest expense booked in the first nine months, fourth-quarter interest is about $11.1 million by our math.
❓ Key Questions
How can Clinical revenue rise in Q4 without marketing?
By our math, the 25% full-year Clinical revenue target requires $40.1 million in the fourth quarter, up from $38.0 million in the third. Because third-quarter ending subscribers fell 12% to 174 thousand, either subscriber additions or revenue per member must jump before January.
Did the 26% Behavioral drop trigger an impairment test?
At the annual test in May 2026, the Behavioral unit's goodwill and the $320 million trade name had fair values within 10% of their carrying amounts. Basic Core subscribers have since fallen 34% from a year ago by our math.
What are the renewal rates on 12-month Clinical plans?
Weight Watchers launched 12-month Clinical commitment plans in the third quarter of 2025. Those initial cohorts are now up for renewal, and the release did not disclose what share of members stayed on or whether their monthly price changed.
What did the $6.8 million of executive costs cover?
The company added back $1.4 million of "expenses in connection with the management of certain executive matters" to Adjusted EBITDA in the third quarter and $6.8 million over nine months. Management has not broken down how much went to severance, search fees or sign-on packages.